Skip to content

Validation of the Classification for Resectability and Ablatability Criteria for the Treatment of Liver Only Colorectal Metastases

Validation of the Classification for Resectability and Ablatability Criteria for the Treatment of Liver Only Colorectal Metastases

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07569341
Enrollment
116
Registered
2026-05-06
Start date
2021-11-01
Completion date
2026-04-01
Last updated
2026-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Adenocarcinoma Metastatic in the Liver

Keywords

Colorectal liver metastasis, classification

Brief summary

The aim of this study is to validate a proposed classification system regarding overall survival as well as a comparison with patients with liver metastases and extrahepatic metastasis of colorectal cancer. The study also aims to identify the proportion of patients in each group, the proportion of patients converted from 4c to 4b and to compare survival to the patients only treated with chemotherapy.

Interventions

PROCEDURELiver resection

Removal or destruction of liver tumors

Sponsors

University Hospital, Linkoeping
Lead SponsorOTHER
Linkoeping University
CollaboratorOTHER_GOV

Study design

Observational model
COHORT
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Colorectal liver metastasis. * Discussed at a multidisciplinary tumor board

Exclusion criteria

* Age less than 18 years. * Previous cancer in the gastrointestinal tract * Ongoing oncological treatment for cancers other than gastrointestinal cancers

Design outcomes

Primary

MeasureTime frame
Overall survival3 years

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 7, 2026